Avid Therapeutics, Inc.

Basic Information

2101 WOODRUFF MEMORIAL RES BLD
Philadelphia, PA, 19104

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. NEW TREATMENT STRATEGIES FOR HEPATITIS C

    Amount: $100,000.00

    N/A

    STTR Phase I 1998 Department of Health and Human Services
  2. Hepatitis B Virus Polymerase as an Antiviral Drug Target

    Amount: $49,410.00

    There are 300 million people in the world who are chronically infected with hepatitis B virus (HBV). Available therapies for the elimination of HBV infection often have a transient effect only. These ...

    SBIR Phase I 1993 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government